Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Inflammatory Bowel Diseases|June 21, 2026
Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registryMontserrat Guasch, Margalida Calafat, Carla J Gargallo-Puyuelo, et al.
Inflammatory Bowel Diseases|April 23, 2019
Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA RegistryFiorella Cañete, Míriam Mañosa, María José Casanova, et al.
Journal of Crohn'S & Colitis|December 5, 2021
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA RegistryMargalida Calafat, Míriam Mañosa, Elena Ricart, et al.
Digestive Diseases and Sciences|July 17, 2020
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA RegistryAlicia Algaba, Iván Guerra, Elena Ricart, et al.
Journal of Clinical Medicine|July 9, 2022
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCUSabino Riestra, Carlos Taxonera, Yamile Zabana, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA RegistryLucía Madero-Velázquez, Ruth de Francisco, Belen Herreros, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2018
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registryMaría Chaparro, Ana Garre, Elena Ricart, et al.
Postgraduate Medical Journal|June 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA projectCarlos González-Muñoza, Margalida Calafat, Javier P Gisbert, et al.
Pharmaceutics|May 25, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDACelia Gómez-Labrador, Elena Ricart, Marisa Iborra, et al.
Journal of Crohn'S & Colitis|July 31, 2023
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA RegistryMaría José García, Montserrat Rivero, Agnès Fernández-Clotet, et al.
Pageof 14